Palisade Bio, Inc. (PALI) Earnings
Palisade Bio, Inc. is expected to report next earnings on November 9, 2026 (in NaN days), with a consensus EPS estimate of $-0.06. PALI has beaten EPS estimates in 5 of its last 12 reported quarters (average surprise -13.9% over the last four).
Next earnings
Nov 9, 2026in NaN days
EPS est $-0.06 · Revenue est $465302
Track record
Beat EPS in 5 of 12 quarters
Avg surprise -13.9% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 10, 2026 | $-0.05 | $-0.05 | +4.3% | $500000 | +0.0% |
| May 12, 2026 | $-0.04 | $-0.05 | -25.0% | — | — |
| Mar 23, 2026 | $-0.02 | $-0.04 | -100.0% | — | — |
| Mar 24, 2025 | $-1.99 | $-0.69 | +65.3% | $4000 | — |
| Nov 9, 2023 | $-0.39 | $-7.35 | -1784.6% | — | — |
| Aug 11, 2023 | $-0.45 | $-7.95 | -1666.7% | — | — |
| May 12, 2023 | $-0.72 | $-8.10 | -1025.0% | $250000 | — |
| Mar 22, 2023 | $-2.43 | $6.47 | +366.3% | — | — |
| Nov 14, 2022 | $-4.00 | $-59.97 | -1399.3% | — | — |
| Aug 15, 2022 | $-8.50 | $-89.96 | -958.4% | — | — |
| May 13, 2022 | $-210.00 | $-194.90 | +7.2% | — | — |
| Mar 16, 2022 | $-11.75 | $554.72 | +4821.0% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.